טוען...

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Prostate cancer is the second most common cancer in men worldwide and causes over 250,000 deaths each year(1). Overtreatment of indolent disease also results in significant morbidity(2). Common genetic alterations in prostate cancer include losses of NKX3.1 (8p21)(3,4) and PTEN (10q23)(5,6), gains o...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Barbieri, Christopher E., Baca, Sylvan C., Lawrence, Michael S., Demichelis, Francesca, Blattner, Mirjam, Theurillat, Jean-Philippe, White, Thomas A., Stojanov, Petar, Van Allen, Eliezer, Stransky, Nicolas, Nickerson, Elizabeth, Chae, Sung-Suk, Boysen, Gunther, Auclair, Daniel, Onofrio, Robert, Park, Kyung, Kitabayashi, Naoki, MacDonald, Theresa Y., Sheikh, Karen, Vuong, Terry, Guiducci, Candace, Cibulskis, Kristian, Sivachenko, Andrey, Carter, Scott L., Saksena, Gordon, Voet, Douglas, Hussain, Wasay M., Ramos, Alex H., Winckler, Wendy, Redman, Michelle C., Ardlie, Kristin, Tewari, Ashutosh K., Mosquera, Juan Miguel, Rupp, Niels, Wild, Peter J., Moch, Holger, Morrissey, Colm, Nelson, Peter S., Kantoff, Philip W., Gabriel, Stacey B., Golub, Todd R., Meyerson, Matthew, Lander, Eric S., Getz, Gad, Rubin, Mark A., Garraway, Levi A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3673022/
https://ncbi.nlm.nih.gov/pubmed/22610119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ng.2279
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!